RNA Society Annual Meeting 2024
From Target Discovery to Preclinical Application: A Workflow for ASO Development
EASL Congress 2024
The Role and Therapeutic Potential of miR-22 in MAFLD and Obesity: From Mouse Model to Human Relevance
MASH and Fibrosis Keystone Symposium 2024
The therapeutic potential of microRNA-22 in MASH and obesity
AASLD: The Liver Meeting 2023
Tackling metabolic disorders with non-coding RNAs
BioJapan 2023
Combinatory treatment with miR-22 ASO and GLP-1 RA increases positive outcomes on body weight and liver parameters in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
EASL Congress 2023
miR-22 inhibition as GLP1 agonist orthogonal mechanism for NAFLD and NASH treatment
OTS Annual Meeting 2023
Anti-miR-22 therapy for NAFLD and obesity: from target discovery to clinical development
Italian Society of Obesity National Congress 2023
miR-22 represents a key regulator of lipid homeostasis
International Congress on Obesity 2024
Anti-miR-22 therapy for obesity and MAFLD: from target discovery to clinical development
